A novel predictor in patients with coronary chronic total occlusion: systemic immune-inflammation index: a

Muhammed Demir1, Mehmet Özbek1

  • 1Dicle University, School of Medicine, Department of Cardiology - Diyarbakır, Turkey.

Revista Da Associacao Medica Brasileira (1992)
|May 18, 2022
PubMed

Insights

The systemic immune-inflammation index predicts mortality in chronic coronary total occlusion patients but not other adverse cardiovascular events. Higher index scores correlate with lower survival and myocardial infarction-free survival rates.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Prognostic Biomarkers

Background:

  • Severe inflammation is linked to cardiovascular events, particularly in coronary artery disease patients.
  • The prognostic significance of the systemic immune-inflammation index (SII) in chronic coronary total occlusion (CTO) requires further investigation.

Purpose of the Study:

  • To evaluate the prognostic value of the systemic immune-inflammation index (SII) in predicting mortality and clinical outcomes.
  • To determine the association between SII and major adverse cardiovascular events in patients with CTO.

Main Methods:

  • A cohort of 366 consecutive patients with CTO was analyzed.
  • Clinical endpoints included all-cause mortality, target vessel revascularization, myocardial infarction, and cerebrovascular events over a median follow-up of 49 months.
  • Statistical analyses comprised multivariate logistic and Cox regression, and Kaplan-Meier survival analysis.

Main Results:

  • The systemic immune-inflammation index (SII) was significantly associated with all-cause mortality (multivariate Cox regression).
  • Higher SII scores were linked to reduced survival rates and myocardial infarction-free survival.
  • SII did not show a significant association with target vessel revascularization, myocardial infarction, or cerebrovascular events.

Conclusions:

  • The systemic immune-inflammation index (SII) is a valuable tool for predicting mortality in patients with chronic coronary total occlusion.
  • SII demonstrated limited utility in predicting other adverse cardiovascular outcomes such as myocardial infarction or stroke.
  • Larger multicenter studies are recommended to further elucidate the role of SII in clinical outcomes for CTO patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
27
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
81
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
42
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
58
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
74
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
50